Estrogen and Androgen Receptors as Comediators of Breast Cancer Cell Proliferation: Providing a New Therapeutic Tool

Archives of Surgery

Volumn 139, Issue 1, 2004, Pages 50-54

  Toth Fejel, SuEllen ^a   Cheek, Julie ^b   Calhoun, Kristine ^a   Muller, Patrick ^a   Pommier, Rodney F ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b AKRON GENERAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROGEN RECEPTOR; BICALUTAMIDE; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PRASTERONE SULFATE; TAMOXIFEN CITRATE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; IMMUNOASSAY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CELL DIVISION; DEHYDROEPIANDROSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0347628894     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.1.50     Document Type: Article

References (30)

1. Shim WS, Conaway M, Masamura S, et al. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo. Endocrinology. 2000;141:396-405.
2. Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. Oncogene. 2002;21:4000-4008.
3. Htun H, Holth LT, Walker D, Kavie JR, Hager GL. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell. 1999;10:471-486.
4. Govind AP, Thampan RV. Proteins interacting with the mammalian estrogen receptor; proposal for an integrated model for estrogen receptor mediated regulation of transcription. J Cell Biochem. 2001;80:571-579.
5. Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor transcription and transactivation: estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res. 2000;2:335-344.
6. Nilsson S, Gustafsson J-A. Estrogen receptor transcription and transactivation: basic aspects of estrogen action. Breast Cancer Res. 2000;2:360-366.
7. Sanchez R, Nguyen D, Rocha W, White JH. Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays. 2002;24:244-254.
8. Green S, Chambon P. A superfamily of potentially oncogenic hormone receptors. Nature. 1986;324:615-617.
9. Carson-Jurica MA, Schrader WT, O'Malley BW. Steroid receptor family: structure and functions. Endocr Rev. 1990;11:201-220.
10. Dickson RB, Lippmann ME. Growth factors in breast cancer. Endocr Rev. 1995;16:559-589.
11. Brooks SC, Pauley RJ. Breast cancer biology. In: Dulbecco M, ed. Encyclopedia of Human Biology. San Diego, Calif: Academic Press; 1997:261-274.
12. Hankinson SE, Willett WC, Manson JE, et al. Plasma sex steroid hormone levels and risk of breast cancer. J Natl Cancer Inst. 1998;90:1292-1299.
13. Hortobagyi GN. Treatment of breast cancer. N Engl J Med. 1998;339:974-984.
14. Isola JJ. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol. 1993;170:31-35.
15. Brys M, Wojcik M, Romanowicz-Makowska H, Krajewska WM. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies. J Cancer Res Clin Oncol. 2002;128:85-90.
16. Gatto V, Aragno M, Gallo M, et al. Dehydroepiandrosterone inhibits the growth of DMBA-induced rat mammary carcinoma via the androgen receptor. Oncol Rep. 1998;5:241-243.
17. Chang H-G, Miyamoto H, Marwah P, et al. Suppression of Δ5-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells. Proc Natl Acad Sci U S A. 1999;96:11173-11177.
18. Bruder JM, Sobek L, Oettel M. Dehydroepiandrosterone stimulates the estrogen response element. J Steroid Biochem Mol Biol. 1997;62:461-466.
19. Boccuzzi G, Brignardello E, di Monaco M, et al. 5-En-androstene-3β, 17β-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol. Br J Cancer. 1994;70:1035-1039.
20. Hackemberg R, Turgetto I, Filmer A, Schulz K. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3β, 17β-diol in human mammary cancer cells. J Steroid Biochem Mol Biol. 1993;46:597-603.
21. Boccuzzi G, Tamago E, Brignardello E, di Manco M, Aragno M, Danni O. Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide. J Cancer Res Clin Oncol. 1995;121:150-154.
22. Le Bail JC, Allen K, Nicolas JC, Habrioux G. Dehydroepiandrosterone sulfate estrogenic action at its physiological plasma concentration in human breast cancer cell lines. Anticancer Res. 1998;18:1683-1688.
23. Maggiolini M, Donze O, Jeannin E, Ando S, Picard D. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. Cancer Res. 1999;59:4864-4869.
24. Poortman J, Prenen J, Schwarz F, Thijssen J. Interaction of 5-en-androstene-3β-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J Clin Endocrinol Metab. 1975;40:373-379.
25. Kreitmann B, Bayard F. Androgen interaction with the oestrogen receptor in human tissues. J Steroid Biochem. 1979;11:1589-1595.
26. Morris KT, Toth-Fejel S, Schmidt J, et al. High DHEA-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy. Surgery. 2001;130:947-953.
27. Calhoun K, Pommier R, Cheek J, Fletcher W, Toth-Fejel S. The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast cancer progression. Am J Surg. 2003;185:411-415.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
29. Keydar I, Chen L, Karby S, et al. Establishment and characterization of a cell line of human breast carcinoma origin. EurJ Cancer. 1979;15:659-670.
30. Tomlinson GE, Chen TT, Stastny VA, et al. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation. Cancer Res. 1998;58:3237-3242.